Global Patient Perspectives Roundtable
Navigating Telehealth/Telemedicine & Embracing Shared Decision-Making
Recorded on Saturday, November 21, 2020
This Global Patient Perspectives Roundtable—focused on Telehealth/Telemedicine and Shared Decision-Making—is the first in a series of four roundtables sponsored by GSK. These topics are relevant to patient care and outcomes, options, and autonomy and are especially significant in the backdrop of COVID-19 and of global discussions of health equity. Participating in this active exchange of information across populations, specialties, and regions, attendees will enhance their understanding of these important topics and be more empowered to exercise their rights and options related to each.
Member, IGCS Council
Gynecologic Oncologist, University Campus Bio Medico of Rome
Executive Vice President, Patient Advocacy & Engagement, National Patient Advocate Foundation & Patient Advocate Foundation, USA
Breast Surgical Oncologist & Assistant Professor of Surgery, Aga Khan University Hospital
Cervical Cancer Survivor & Advocate
Oncology & Research Nurse
IMSUT Hospital of the Institute of Medical Science, University of Tokyo
Graziela Zibetti Dal Molin
Beneficência Portuguesa de São Paulo Hospital
Professor & Founding Director, Center of Community Alliance for Research & Education, City of Hope National Medical Center
About the IGCS Patient Perspectives Roundtable Series
During the COVID-19 pandemic and in its aftermath, IGCS will continue to be a global source of education and resources, training, public awareness, and advocacy. Virtual Roundtables will
- facilitate first-hand assessment of patient community needs and concerns
- provide vetted information, assessments, and guidance from key opinion leaders and seasoned survivors/advocates
- address current patient and wider community concerns through live responses to question posted online during the session
- promote strategic conversations with health care and research communities around specific issues
- assist all in coming to workable solutions and strategies for moving forward during the COVID-19 pandemic and in its aftermath
Each 60- to 90-minute session will cover a specific topic important to the gynecologic cancer patient communities maneuvering through the health and cancer care system during and after COVID-19 and will include IGCS key opinion leaders, patients-caregivers, and other stakeholders appropriate to the topic.
IGCS is hosting a Spanish-language webinar in collaboration with our Latin American Strategic Alliance Partners.
The live event will be held in Spanish with English translation. The recording will be Spanish only.
Selected Topics in Gynecologic Oncology Webinar
Tópicos selectos en Ginecología Oncológica Seminario Web
Saturday, December 5, 2020 | Sábado, Diciembre 5, 2020
9:00 am—12:00 pm EST
Registration is free but required.
- To understand the current status of surgical options in ovarian cancer.
- To update the current indications of Neo-adjuvant chemotherapy in cervical cancer.
Clemente Arab, MD
Instituto Oncológico FALP
Magaly Malca, MD
Hospital Edgardo Rebagliati Martins
Pedro Ramirez, MD
The University of Texas – MD Anderson Cancer Center
What is new in surgical treatment of ovarian cancer
Reitan Ribeiro, MD
Erasto Gaertner Hospital
… What if TRUST trial has a positive result?
Alejandro Rauh-Hain, MD
The University of Texas – MD Anderson Cancer Center
… What if TRUST trial has a negative result?
Myriam Perrotta, MD
Hospital Italiano de Buenos Aires
Impact of the HPV vaccination on cervical cancer mortality
Juliana Rodriguez, MD
Instituto Nacional de Cancerología
Neo-adjuvant chemotherapy in pregnant women with cervical cancer
Fabio Martinelli, MD
Fondazione IRCCS Istituto Nazionale dei Tumori
Neo-adjuvant chemotherapy in cervical cancer state-of-the-art
René Pareja, MD
Instituto Nacional de Cancerología-Bogota; Clínica de Oncología Astorga-Medellín
Neo-adjuvant chemotherapy and fertility preservation in cervical cancer
Login to the IGCS Education Portal to access new resources recently uploaded in the Pathology Corner:
- WHO Classifications of Female Genital Tumors – 5th Edition Update
- Download comprehensive summaries of the 5th edition update of the WHO Blue Books created by members of the IGCS Pathology Work Group for cervix, ovary, uterine, vulvar, and vaginal cancers.
- Literature Highlights: Four new articles have been uploaded in addition to the summaries of papers from ISGyP’s Endometrial Carcinoma Project published in the International Journal of Gynecological Pathology.
- Uterine Endometrial Stromal Tumors with Limited Infiltration: First Report of a Case Series Indicating Potential for Malignant Behavior
- Practical Guidance for Measuring and Reporting Surgical Margins in Vulvar Cancer
- Molecular Subtypes of Clear Cell Carcinoma if the Endometrium: Opportunities for Prognostic and Predictive Stratification
- Mismatch Repair Deficiency and Prognostic Significance in Patients with Low-Risk Endometrioid Endometrial Cancers
- Interesting Cases: Two case reviews are now available with images and descriptions diagnosing:
- Struma Ovarii
- Papillary Thyroid Carcinoma Arising in Mature Cystic Teratoma
While you are exploring the Pathology Corner, make sure to view the educational lectures, download the terms & definitions of commonly used IHC stains in gynecologic oncology and please feel free to send an email to email@example.com to submit your pathology-related questions to the IGCS Pathology Work Group members.
Under the direction of Anna Plotkin, Pathology Work Group Lead, and with significant contributions from our Strategic Alliance Partner Members at the International Society of Gynecological Pathologists (ISGyP), the corner was created to streamline pathology related education curated specifically for gynecologic oncologists. We would like to acknowledge and express gratitude to our work group members for their efforts: Anna Plotkin, Work Group Lead (Canada), Blake Gilks (Canada), Siobhan O’Connor (USA), Joseph Rabban (USA), Adrian Suarez (USA), Gulisa Turashvili (Canada), and Rachael van der Griend (New Zealand) and all the contributors who have agreed to share content.
We hope you enjoy the new educational content in the Pathology Corner of the IGCS Member Education Portal!
IJGC Editorial Fellowships
The Editorial Team at the International Journal of Gynecological Cancer is offering a 4-month Editorial Internship from February-May 2021 for all those interested in learning about the processing of manuscript submission, peer-review analysis, revisions, and ultimately production and publication, as well as journal management and strategy.
This experience will match the Editorial Fellow with the Editor-in-Chief, and together they will work to assure for a very positive and productive learning experience.
We look forward to working on this very exciting project.
During their appointment, fellows will gain experience in peer review processing, proposal/manuscript development, medical journal production, working with authors, editorial board management, and implementing a strategic vision plan. The objectives of the project are:
- Increase interest in “editorial” and other publication-related activities for trainees and fellows
- Increase understanding and participation in the IJGC review process
- Tighten the relationship between the “new” generation of gynecological oncologists and more experienced generations
- Increase the visibility of IJGC among younger gynecological oncologists
The Fellows will participate in manuscript decisions, strategic planning for the journal, editorial team conference calls, and journal’s annual meeting. In addition, the fellow will work on special projects based on personal areas of interest and the needs of the IJGC and Editor-in-Chief expectations. Fellows will develop the skills to further their own research careers and effect change in the quality of medical research. Examples of activities undertaken during the Fellowship might include the following:
- Serve as Editorial Fellow for 4 months.
- Peer review of manuscripts and consult with the Editor-in-Chief on peer review
- Learn how electronic manuscript review systems work
- Be involved in the final decision of selected manuscripts together with the Editor-in-Chief
- Participate in monthly Associate Editors telephone conference calls
- Participate in all meetings of the Editors during the annual meetings of IJGC as per candidate’s availability
- Recruit trainees as reviewers as determined by the Editor-in-Chief
- Develop on-line initiatives (depending on the needs)
- Prepare and participate in IJGC’s monthly Twitter Journal Club
- Assist the Social Media Editor with promotion of the journal through Facebook and Twitter, including posting from the @IJGCfellows Twitter account
- Assist with developing content by identifying potential authors and topics for invited articles, such as Review Articles, Clinical Trials, Corners of the World, and Podcasts
- Final report to the Editor-in-Chief demonstrate what was learned during the program
The IJGC Editorial Fellowship is designed for a junior faculty or fellow who wishes to build skills and gain experience through active participation in the IJGC editorial team.
Candidates must have documented interest in gynecologic oncology, such as:
- fellowship/residency in oncological gynecology, radiotherapy or medical oncology (completed or in progress)
- work in an oncology center
- documented publishing experience
- involvement in IGCS, IGCS Early Career Network, ESGO, or ENYGO activities is an advantage
To apply, candidate should send:
- CV (maximum 2 pages)
- Letter of interest (one page, please be as specific as possible in detailing the reason for interest in the Editorial Fellowship and how it would benefit to you)
- Letter of recommendation from the Head of the Department or from an ESGO or IGCS Member with a statement of protected time for the performance of the fellowship functions
- List of publications or performed reviews
- Proof of proficiency in English is absolutely necessary
Applications should be sent to firstname.lastname@example.org with the subject line “IJGC Editorial Fellowship Application.”
Applications will close on December 1, 2020. Interviews will be held between December 7, 2020 and December 18, 2020. Fellows will be selected by January 4, 2021.
The Editor-in-Chief evaluate the applications and select 4 individuals to become Fellows. The decision is final without right of appeal.
2020 Virtual Advocacy Survivor-Caregiver Public Summit: Women4Women
Promoted and hosted by the IGCS
This summit was held live on Saturday, September 26, 2020
View the video recording below.
Gynecologic Cancer Literacy
We covered all the basics of gynecologic cancers: symptoms and risks, early detection, hereditary breast and ovarian cancer, genetic testing, and patient rights and options such as maintenance therapy. This session would not be complete without discussing clinical trials and cutting-edge research and findings.
Survivorship 101: Focus on Quality of Life
Let’s talk Survivorship—quality of life and wellness from diagnosis onward—and get very personal! We had frank exchanges about body image, sexual health, intimacy, fertility, nutrition, and self-care as well as about work-life balance and other concerns specific to working women. Participants learned to document their individual journeys.
The Power of Patient Advocacy
While having a primer on the Who, What, When, Where, Why, and How of patient advocacy, this segment tapped into regional and global power and the benefits of creating and maintaining a strong, inclusive Global Advocacy Network.
Optional Bonus Session
Following the plenary Summit sessions, an optional session was available for Summit participants which covered these topics: (1) Treatment, Clinical Trials, Telemedicine/Telehealth in Backdrop of COVID-19 and (2) Patient-Centric Table Talk: Education & Exchange Session.
To access the IGCS 2020 xDigital Annual Global Meeting Portal, go to 2020.igcsmeeting.com
Registered Delegates: Your unique access code was sent via email in a message from email@example.com with the subject line “IMPORTANT: DELEGATE PASS – IGCS xDigital.”
If you cannot find the email message with your access code, please check your spam filter first.
If you cannot locate the message, please email firstname.lastname@example.org.
💬 Help and support
A dedicated email and live chat will be available to delegates 24 hours a day throughout the congress for any assistance or queries that arise. Access the live chat through the Help and Support page on 2020.igcsmeeting.com when the congress portal is open or email us at email@example.com.
🖥️ Browser Requirements
The browsers listed below are compatible with the congress portal:
• Windows: Edge 12+, IE 11+, Firefox 27+, Chrome 30+
• Mac: Recommended: Chrome 30+ (Safari is not supported)
• Linux: Firefox 27+, Chrome 30+
💻 Operating System Requirements
Check your computer’s operating system before the start of the congress to ensure the software works with the congress portal. See below list of compatible operating systems:
• MacOS X with macOS 10.7 or later
• Windows 10*, 8.1, 8, 7
• Red Hat Enterprise Linux 6.4 or higher
• iOS 7.0 or later
• iPadOS 13 or later
• Android 4.0x or later
*Windows 10 Home, Pro or Enterprise only. S Mode is not supported.
Symposium – Desktop device
We recommend viewing the symposium on your desktop device for the best experience.
The xDigital platform is a unique, custom-built environment that leverages a number of different technologies. One of these technologies is Zoom. Please check your company usage policies if you are using company equipment to access the congress. If Zoom is prohibited, you will need to request special dispensation to use it, or arrange an alternative device.
Download the abstracts to be presented at the IGCS 2020 Annual Global Meeting:
Learn more about IGCS 2020 and register at igcsmeeting.com.
Registered delegates should have received their unique login code to access the Meeting Portal via email from firstname.lastname@example.org on or after September 2nd, depending on when they registered. If you have not received the email, please check your spam filter first. If you have not received your code, email email@example.com for assistance.